Utilizing multiple models, including human lung cancer cells, human lung organoids and Ad-ACE2-transduced WT mice, we demonstrated that enzalutamide failed to inhibit SARS-CoV-2 infection, which was attributed to the lack of AR-driven modulation of TMPRSS2 expression in lung epithelial cells. Here, AR is linked to lung carcinoma.